Early GLP-1 Receptor Agonist and SGLT2 Inhibitor Add-On Strategies in Adults With Obesity, Type 2 Diabetes, Cardiovascular-Kidney-Metabolic Syndrome Stage 2-3, and Metabolic Dysfunction-Associated Steatotic Liver Disease
Clinical trial NCT07566299 · COMPLETED
Trial details
- NCT number
- NCT07566299
- Sponsor
- Chung Shan Medical University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-01
- Primary completion
- 2026-03-31
- Enrollment
- 118805
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.